Anaesthesia, movement and emesis.
One hundred and eighty-two women undergoing dilatation and curettage were allocated randomly to receive premedication comprising temazepam, papaveretum-hyoscine or placebo. The temazepam recipients reported significantly fewer episodes of postoperative nausea. Movement was blamed by 66% of patients who identified a cause for nausea. These patients had higher scores on a motion sickness susceptibility questionnaire and were more likely to have been treated previously for nausea or vomiting. It may be possible to identify susceptible patients before surgery.
Department of Anaesthesia, City Hospital and Queen's Medical Centre, Nottingham.
B
B
Kamath
J
J
Curran
C
C
Hawkey
A
A
Beattie
N
N
Gorbutt
H
H
Guiblin
A
A
Kong
D000328:Adult; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D009041:Motion Sickness / Q000209:etiology; D009068:Movement / Q000502:physiology*; D009325:Nausea / Q000139:chemically induced* / Q000517:prevention & control; D009892:Opium; D011229:Preanesthetic Medication / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D012601:Scopolamine; D013693:Temazepam; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control
D009892:Opium; D013693:Temazepam; D012601:Scopolamine